Syros Pharmaceuticals, Inc. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Syros Pharmaceuticals, Inc. for February 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Kuvalanka Kyle D. | Chief Operating Off ... | Option Exercise | A | 10.90 | 78,000 | 850,200 | 78,000 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.90 | 175,000 | 1,907,500 | 175,000 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 10.90 | 63,500 | 692,150 | 63,500 | |
Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.90 | 40,000 | 436,000 | 40,000 |